The Maryland Center for Multiple Sclerosis is recognized for the design and conduct of clinical trials in multiple sclerosis, comprehensive care of MS patients at all stages of their disease, and the conduct of basic science research to better understand the pathogenesis of MS. The Center cares for one-third of the MS population in the state of Maryland and approximately 1200 patient visits occur annually.

Care is provided in a new ambulatory center at the University of Maryland and in an active MS day program located at an affiliated rehabilitation facility, University of Maryland Rehabilitation & Orthopaedics Institute formerly Kernan Hospital. Comprehensive care is provided; this includes diagnostic and second opinion consultation for ambulatory of patients, hospitalization for seriously ill patients, and rehabilitative care.

The clinical trials program has been very successful and the center is credited for playing a major role in the development of Betaseron and Glatiramer acetate for the treatment of MS. A number of industry sponsored clinical trials and peer-reviewed, MS-related grants from the NIH, the National Multiple Sclerosis Society, and the VA Research Service are active in order to specifically seek a better treatment and understanding of the pathogenesis of MS.

More Information